Paul Kariuki: Why Altruism Isn’t Enough to Save Kenya’s Blood System
Paul Kariuki, Founder at Comms for Health Africa Consultancy, shared on LinkedIn:
“We do not have a blood donor problem.
We have a donor experience optimisation problem.
We do not have a willingness-to-donate problem.
We have a capacity-to-make-the-system-work problem.
We do not have a shortage of altruism.
We have a shortage of fiscal and systemic will to make the blood system work.
Beyond blood donor mobilisation and collection, we must think about every other component that keeps the system running.
Over the past financial year, different regions have experienced outages of reagents.
Our Ministry of Health, Kenya is structured such that all pharmaceuticals and non-pharmaceutical products are procured by Kenya Medical Supplies Authority and then distributed to different departments and divisions.
One of the key elements in the blood ecosystem is reagent kits.
These are necessary for blood safety because blood is considered both a medicine and a bio-safety product.
Blood donated cannot simply be transfused.
Even if we were to collect enough units of blood today to meet total demand, it still would not be enough if we were unable to process and distribute it to the patients in need.
To address this, we must focus on four key areas:
- Local Solutions: We must find local solutions to mitigate these procurement, logistics, and processing challenges.
- Fiscal Support: We must identify sustainable fiscal support to fill the gap, especially in Kenya, occasioned by the underfunding of the blood service.
- Regional Learning: We must look to other jurisdictions, especially other countries in Africa, that have a firm grip on the logistics and procurement issues surrounding reagents.
- Stakeholder Collaboration: We must collaborate across the sector to ensure that these shortages do not recur in the new financial year 2026–2027.
What is your experience with the National Blood Service?
How is your country performing in terms of timely and sustainable access to reagents?”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 19:53Tareq Abadl: Post-Transfusion Reactions – Can You Identify the Cause?
-
Jul 5, 2026, 19:46Nawsherwan Mohammad: Exploring Thrombophilia in 2026
-
Jul 5, 2026, 19:35Luise Erpenbeck: When Immune Cells Speak the Language of Neurons
-
Jul 5, 2026, 19:14Mubariz Ahsan: Bringing Stroke Research to a Wider Audience
-
Jul 5, 2026, 18:58Linda Hayes Bennett: Redefining Ferroptosis in Aging and Neurodegenerative Conditions
-
Jul 5, 2026, 18:20LV Aneurysm, Thrombus, and Embolism: A Silent Post-MI Threat – Abdallah Othman
-
Jul 5, 2026, 17:58Andaleb Kholmukhamedov: What’s the Most Unusual “False Positive” Trigger You’ve Seen Elevate a D-Dimer?
-
Jul 5, 2026, 17:47Michiel Coppens: Supporting Better Hemophilia Care in Suriname
-
Jul 5, 2026, 17:31Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease